Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
325–360
Headlines
1711
Sources here
14
Companies here
12
Current section United States Drug Manufacturers - General news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

finance.yahoo.com Earnings Main company 🇺🇸 United States

What Johnson & Johnson (JNJ)'s OTTAVA FDA Win and Talc Deal Shift Mean For Shareholders

In recent months, Johnson & Johnson reported strong Q2 2026 results, received FDA De Novo authorization for its OTTAVA soft-tissue robotic surgery system, advanced its RYBREVANT FASPRO oncology franchise with an FDA Priority Review, announced a US$5.50 billion talc settlement framework, and agreed to …

JNJ main company
Sharemaestro market context Trend signal active 52 weeks +50.4% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Crain's Chicago Business Regulatory and legal Main company 🇺🇸 United States

Pharma giants, including AbbVie, sue to block Illinois drug discount law

Major pharmaceutical companies, including AbbVie, Bristol Myers, and Novartis, have filed a lawsuit to block a new drug discount law in Illinois. The lawsuit challenges the state's 340B law, which aims to provide discounted prescription drugs. This legal action by the pharma giants indicates …

ABBV main company
Sharemaestro market context Trend signal active 52 weeks +21.9% · Next-week setup positive 56.3% ABBV stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇺🇸 United States

Can AstraZeneca (AZN) Reach Its $80 Billion Revenue Goal Despite Clinical Setbacks?

It was reported on July 27 that AstraZeneca PLC (NASDAQ:AZN) shares outperformed in European trading after the company reported second-quarter earnings that beat Wall Street expectations and reiterated its full-year 2026 guidance. Core earnings per share (EPS) jumped 18% on a constant exchange rate …

AZN main company
Sharemaestro market context Price below Trend Line 52 weeks +4.1% AZN stored weekly price path from 15 Aug 2025 to 7 Aug 2026
FOX 26 Houston Market update Main company 🇺🇸 United States

New Bristol Myers Squibb facility coming to Generation Park

Global biopharmaceutical company Bristol Myers Squibb is set to establish a new pharmaceutical manufacturing campus in the Houston area, specifically near Generation Park. FOX 26's Karys Belger reported on this development. The facility will mark a significant expansion for the company in the region.

BMY main company
Sharemaestro market context Trend signal active 52 weeks +38.5% BMY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇺🇸 United States

Why the Amlitelimab Setback Isn’t Enough to Sink Sanofi’s Multi-Billion Dollar Engine

It was reported on July 24 that Sanofi (NASDAQ:SNY) shares underperformed in European trading following the company's decision to drop the clinical development of its eczema candidate, amlitelimab, for moderate-to-severe atopic dermatitis. Rather than a fundamental breakdown, the move reflects an aggressive R&D pipeline …

SNY main company
Sharemaestro market context Price below Trend Line 52 weeks -7.8% · Next-week setup positive 55.6% SNY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Analyst action Main company 🇺🇸 United States

Eli Lilly (LLY) Stock Gets Fair Value Bump After GLP 1 Driven Analyst Revisions

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Eli Lilly's updated fair value price target has shifted from US$1,270.37 to US$1,297.31, giving investors a fresh reference point for how analysts are framing the …

LLY main company
Sharemaestro market context Trend signal active 52 weeks +69.9% · Next-week setup positive 58.2% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇺🇸 United States

Johnson & Johnson vs. Medtronic: Which Healthcare Stock Is Better Positioned After Earnings?

Johnson & Johnson (NYSE:JNJ) delivered another strong quarter in fiscal Q2 2026, with reported sales increasing 6.6% year over year to $25.31 billion and surpassing analysts' average estimate of around $25.05 billion. Adjusted earnings per share reached $2.90, also exceeding estimates of $2.85. The …

JNJ main company
Sharemaestro market context Trend signal active 52 weeks +50.4% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Market update Main company 🇺🇸 United States

Eli Lilly vs. Novo Nordisk: Which Company Is Better Positioned for America’s New Drug Manufacturing Policies?

For years, investors have viewed Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) through one lens: the race to dominate the booming obesity-drug market. But Washington is beginning to shift the conversation. With the U.S. government pushing pharmaceutical companies to manufacture more medicines domestically and …

LLY main company NVO mentioned
Sharemaestro market context Trend signal active 52 weeks +69.9% · Next-week setup positive 58.2% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
nasdaq.com Regulatory and legal Main company 🇺🇸 United States

Why Eli Lilly Topped the Market Today

Key Points This market has a population of almost 60 million. While the drug isn't the first of its type to be sold in that country, it will have Lilly's considerable marketing power behind it.10 stocks we like better than Eli Lilly › Eli …

LLY main company NVO mentioned
Sharemaestro market context Trend signal active 52 weeks +69.9% · Next-week setup positive 58.2% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Market update Main company 🇺🇸 United States

Eli Lilly vs. Novo Nordisk: Has GLP-1 Manufacturing Become the New Competitive Moat?

The obesity-drug market has largely been viewed as a race between clinical innovation and commercial execution. Investors have spent the past three years comparing prescription growth, market share, and pipeline candidates as Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) compete for dominance in one …

LLY main company NVO mentioned
Sharemaestro market context Trend signal active 52 weeks +69.9% · Next-week setup positive 58.2% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Provider-linked mention 🇺🇸 United States

Hims Stock Falls on Earnings. Why a Guidance Hike Isn’t Enough.

Hims faces restructuring charges as it shifts its U.S. weight-loss business away from compounded GLP-1 medications. Continue Reading

NVO mentioned
Sharemaestro market context Price above Trend Line 52 weeks -5.7% NVO stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇺🇸 United States

Johnson & Johnson vs Abbott Laboratories: Which Healthcare Giant Offers the More Compelling Growth Story After Earnings?

Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7% to $25.31 ⁠billion, above analysts' average estimate of about $25.05 billion. Adjusted earnings per share reached $2.90, surpassing the expectation of $2.85. The company also raised …

JNJ main company
Sharemaestro market context Trend signal active 52 weeks +50.4% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

Merck (MRK) animal health chief DeLuca sells 6,050 shares

Richard R. DeLuca, EVP & President of Merck Animal Health, sold a total of 6,050 shares of Merck & Co., Inc. common stock on August 6, 2026. The sales occurred in three separate open-market transactions at weighted-average prices between $130 and $131 per share. …

MRK main company
Sharemaestro market context Trend signal active 52 weeks +57.8% MRK stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

Watch Johnson & Johnson’s Healthcare Conference Chat Sept. 14

Johnson & Johnson (NYSE: JNJ) announced it will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026. Management will host a Fireside Chat at 11:30 a.m. Eastern Time, which will be accessible via a live audio webcast on the …

JNJ main company
Sharemaestro market context Trend signal active 52 weeks +50.4% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026
USA Today Market update Main company 🇺🇸 United States

Pharmaceutical giant to build $2.3B plant, create 500 jobs in Texas

Bristol Myers Squibb is investing $2.3 billion to construct a new drug manufacturing campus in Houston, Texas, creating nearly 500 initial jobs and 2,000 construction jobs. The 600,000-square-foot facility at Generation Park will produce various next-generation medicines. Texas Governor Greg Abbott praised the investment, …

BMY main company
Sharemaestro market context Trend signal active 52 weeks +38.5% BMY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Deals and strategy Provider-linked mention 🇺🇸 United States

Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update

Lakefront Biotherapeutics Completed acquisition of Ouro Medicines with Gilead Sciences to advance potential first and best-in-class T-cell engager Forecast at least €1.6B of cash remaining after funding portfolio to first gamgertamig approval Maintain year-end 2026 cash and financial investments balance guidance of ~€2B, and …

GILD mentioned
Sharemaestro market context Price below Trend Line 52 weeks +15.5% GILD stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Analyst action Provider-linked mention 🇺🇸 United States

Sector Update: Healthcare Stocks Gain Late Afternoon

Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 1% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.4%.The iShares Biotechnology ETF (IBB) climbed 1%.In corporate news, Eli Lilly (LLY) received UK authorization for Silver Upgrade …

LLY mentioned
Sharemaestro market context Trend signal active 52 weeks +69.9% · Next-week setup positive 58.2% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Regulatory and legal Main company 🇺🇸 United States

Eli Lilly Stock Rises 2.1% as UK Clears Obesity Pill

This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY) just added another weapon to its obesity arsenal. The pharmaceutical giant received British authorization for Foundayo on Monday, making the U.K. the first European country to clear the once-daily orforglipron tablet for weight management and …

LLY main company NVO mentioned
Sharemaestro market context Trend signal active 52 weeks +69.9% · Next-week setup positive 58.2% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Eli Lilly and Co Stock (LLY) Moved Up by 3.48% on Aug 10: Drivers Behind the Movement

Eli Lilly and Co (LLY) saw its stock price rise by 3.48% due to an optimistic revision of its full-year guidance and successful resolution of manufacturing bottlenecks for its metabolic treatments. Favorable updates regarding its Alzheimer's drug reimbursement and Medicare coverage, alongside increased institutional …

LLY main company
Sharemaestro market context Trend signal active 52 weeks +69.9% · Next-week setup positive 58.2% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Yahoo! Finance Canada Earnings Main company 🇺🇸 United States

Pfizer, Inc. (PFE) Stock Price, News, Quote & History

This page provides a comprehensive overview of Pfizer, Inc. (PFE) stock information, including its real-time price, recent news, and performance data. The stock closed at $27.05, up 1.08%, with overnight trading activity showing a slight dip to $26.97. Recent news highlights Pfizer's Q2 earnings, …

PFE main company
Sharemaestro market context Price above Trend Line 52 weeks +12.0% PFE stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Deals and strategy Provider-linked mention 🇺🇸 United States

Trump Plans to Sign Order on Splitting Up Combined Measles Shot

(Bloomberg) -- President Donald Trump is expected to sign an executive order Monday that would recommend breaking up the combined measles, mumps and rubella vaccine into three separate shots, according to a person familiar with the matter. Most Read from Bloomberg China Unleashes $28 …

GSK mentioned
Sharemaestro market context Price below Trend Line 52 weeks +37.9% · Next-week setup positive 60.7% GSK stored weekly price path from 15 Aug 2025 to 7 Aug 2026
The Globe and Mail Deals and strategy Main company 🇺🇸 United States

Pfizer's Earnings Have Declined 58% This Year. Is a Dividend Cut Around the Corner?

Pfizer's earnings have fallen 58% this year, largely due to impairment charges, raising concerns about its dividend sustainability. While net income is down, the company's free cash flow of $11 billion over the past four quarters exceeds its dividend payments of $9.8 billion, suggesting …

PFE main company
Sharemaestro market context Price above Trend Line 52 weeks +12.0% PFE stored weekly price path from 15 Aug 2025 to 7 Aug 2026
The Globe and Mail Earnings Main company 🇺🇸 United States

Pfizer Inc (PFE-N) Press Releases

This page aggregates recent news and analyst opinions concerning Pfizer Inc. (PFE-N). It covers topics such as Pfizer's earnings, dividend outlook, advancements in COVID-19 booster strategies with BioNTech, and development of new weight-loss drugs. Various financial analysts and news outlets provide insights into the …

PFE main company
Sharemaestro market context Price above Trend Line 52 weeks +12.0% PFE stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Provider-linked mention 🇺🇸 United States

Jim Cramer Highlights Pharmaceutical Giants as Non-Tech Innovation Plays Like JNJ and LLY

During the August 6 episode of CNBC's Mad Money, Jim Cramer pointed to a growing sector rotation as portfolio managers look for innovation outside the mega-cap technology space. He said: Finally, tech had such a run that portfolio managers want exposure to other sectors …

LLY mentioned JNJ mentioned AZN mentioned AMGN mentioned BMY mentioned
Sharemaestro market context Trend signal active 52 weeks +69.9% · Next-week setup positive 58.2% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Provider-linked mention 🇺🇸 United States

S&P 500 Companies' Quarterly Earnings Growth Eases Amid Healthcare Drop, Oppenheimer Says

S&P 500 companies' quarterly earnings growth rate eased from a week ago amid a drop in the healthcar PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. …

MRK mentioned PFE mentioned
Sharemaestro market context Trend signal active 52 weeks +57.8% MRK stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Provider-linked mention 🇺🇸 United States

Jim Cramer Sees Cheap Valuation in Becton, Dickinson (BDX) After Q3 Beat and Raised Guidance

On August 6, Jim Cramer highlighted Becton, Dickinson and Company (NYSE:BDX) on CNBC's Mad Money following its third-quarter fiscal 2026 financial report and said: This morning, we got a very strong quarter from BD. That's the big medical technology and supply play... That was …

LLY mentioned JNJ mentioned
Sharemaestro market context Trend signal active 52 weeks +69.9% · Next-week setup positive 58.2% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Analyst action Provider-linked mention 🇺🇸 United States

Sector Update: Healthcare Stocks Rise in Afternoon Trading

Healthcare stocks were higher Monday afternoon, with the NYSE Healthcare Index up 0.9% and the State PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already …

LLY mentioned
Sharemaestro market context Trend signal active 52 weeks +69.9% · Next-week setup positive 58.2% LLY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Market source Earnings Main company 🇺🇸 United States

AbbVie’s (ABBV) Botox Just Got A Step Closer To A Fifth Use

AbbVie's Botox Cosmetic has moved closer to FDA approval for a fifth aesthetic use: treating masseter muscle prominence. This potential approval is based on positive Phase 3 study results and aligns with AbbVie's strategy of expanding existing drug indications. While the company shows strong …

ABBV main company
Sharemaestro market context Trend signal active 52 weeks +21.9% · Next-week setup positive 56.3% ABBV stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇺🇸 United States

Bristol Myers Squibb to build $2.3 billion Houston campus

Bristol Myers Squibb announced Monday it will build a $2.3 billion drug manufacturing campus in Houston, Texas, part of the company's broader $40 billion commitment to invest in the United States over five years. The roughly 600,000-square-foot campus will be located at Generation Park, …

BMY main company
Sharemaestro market context Trend signal active 52 weeks +38.5% BMY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Modern Healthcare Deals and strategy Main company 🇺🇸 United States

ASC GPO inks deal with J&J for cardiac electrophysiology tech

Access GPO has finalized a deal with Johnson & Johnson for cardiac electrophysiology technologies, including pulsed field and radiofrequency ablation, 3D mapping, and intracardiac imaging. This partnership aims to enhance ASCs' capabilities in cardiac care. The agreement was announced on August 10, 2026.

JNJ main company
Sharemaestro market context Trend signal active 52 weeks +50.4% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Community Impact Market update Main company 🇺🇸 United States

Bristol Myers Squibb selects Generation Park for new $2.3B manufacturing campus

Bristol Myers Squibb has chosen Generation Park in northeast Houston for its new $2.3 billion manufacturing campus, a project anticipated to create nearly 500 jobs directly and 2,000 construction jobs. The 600,000-square-foot facility will produce various medicines, supporting the company's $40 billion investment in …

BMY main company
Sharemaestro market context Trend signal active 52 weeks +38.5% BMY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Analyst action Provider-linked mention 🇺🇸 United States

The “Set It & Forget It” Stocks I’d Want to Own

Quick Read SBAC tops the group at a 2.58% yield, while JNJ's 64-year dividend streak and AAA credit rating make both core income holdings. $100,000 split equally across all four stocks generates $2,304 in annual passive income, a 2.30% blended yield that compounds as …

JNJ mentioned AMGN mentioned
Sharemaestro market context Trend signal active 52 weeks +50.4% JNJ stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Regulatory and legal Provider-linked mention 🇺🇸 United States

Glioma Market is Set for Tremendous Growth at a CAGR of 15% During the Study Period (2022–2036), as Novel Targeted Therapies and Immunotherapies are Gaining Momentum | DelveInsight

DelveInsight Business Research LLP The glioma market is expected to witness steady growth over the coming years, driven by the rising incidence of primary brain tumors, increasing awareness, and advances in diagnostic technologies. The market is also benefiting from a robust pipeline of therapies, …

MRK mentioned AMGN mentioned PFE mentioned
Sharemaestro market context Trend signal active 52 weeks +57.8% MRK stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Analyst action Provider-linked mention 🇺🇸 United States

Nurix Therapeutics' STAT6 Degrader Likely to Receive Increased Recognition, RBC Says

Nurix Therapeutics' (NRIX) STAT6 degrader NX-3911 is likely to receive increased recognition after advancing into clinical development under its collaboration with Sanofi (SNY), RBC Capital Markets said in a Monday research note.The investment firm said limited preclinical data Silver Upgrade to read this MT …

SNY mentioned
Sharemaestro market context Price below Trend Line 52 weeks -7.8% · Next-week setup positive 55.6% SNY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
MarketWatch Earnings Main company 🇺🇸 United States

Pfizer Inc. stock outperforms competitors on strong trading day

Pfizer Inc. (PFE) shares rose 1.08% to $27.05 on Monday, extending its winning streak to seven consecutive days, despite a generally downbeat trading session for the broader market. The S&P 500 Index fell 0.06%, and the Dow Jones Industrial Average dropped 0.11%, highlighting Pfizer's …

PFE main company
Sharemaestro market context Price above Trend Line 52 weeks +12.0% PFE stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context